Delivery Order SPE2DB24D9144-SPE2DB25FCMQF
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,115.65 by the Defense Logistics Agency on August 8, 2025. The contract, with an ultimate completion date of August 11, 2025, provides for the delivery of Jakafi 10 mg tablets (60-count units) under a firm fixed-price arrangement. This delivery order was issued without a set-aside designation, demonstrating the company's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on August 7, 2025, for the supply of Jakafi 10 mg tablets (60-count units). This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 8, 2025, with performance to be executed in Park Ridge, Illinois. The award represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on August 12, 2025, for the supply of Jakafi 10 mg tablets (60-count). This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 13, 2025. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,231.30 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order is expected to be completed by July 31, 2025, and represents a continuation of the company's significant role as a federal pharmaceutical supplier. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48,462.60 by the Defense Logistics Agency on July 11, 2025, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of July 14, 2025, was issued without a set-aside designation. The contract is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 26, 2025, for the supply of Jakafi 5 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $12,146.79. The Defense Logistics Agency, a component of the Department of Defense, issued this award without a set-aside designation to support military healthcare supply requirements. This delivery order falls under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,293.60 on August 11, 2025, for the supply of Jakafi 5 mg tablets (60-count packages). This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, was issued without a set-aside designation by the Defense Logistics Agency's Medical Supply Chain under the SPE2DB Indefinite Delivery Contract program. The...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units) valued at $72,538.74. This firm fixed-price delivery order, awarded on September 18, 2025, with completion targeted for September 19, 2025, represents a tactical fulfillment under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA. The vendor...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, valued at $12,115.65, was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract carries no set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge, Illinois...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total contract value of $499,999,999 through...
- SPE2DB24D9144Indefinite Delivery Contract
- SPE2DB24D9144-SPE2DB25FCMQFDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on April 22, 2025, for the supply of Jakafi 10 mg tablets (60-count). The order, which carries no set-aside designation, is scheduled for completion by April 23, 2025, and will be performed at the vendor's Park Ridge location. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 single-award contract valid through November 2026 that authorizes the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products. The Defense Logistics Agency utilizes the SPE2DB indefinite delivery vehicle to support pharmaceutical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's contract portfolio demonstrates its established role as a critical supplier in the federal pharmaceutical supply chain, with a track record of delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities. The company's status as a woman-owned small business has enabled it to compete effectively in federal procurement markets while maintaining consistent performance on defense-related pharmaceutical contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 4/22/25 |